Lynx1 Capital Management LP Diversified Active

Location: Dorado, Puerto Rico

CIK: 0001910456 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $153M (100.0% shares, 0.0% debt)

Holdings (18)

— MERUS N V 19.9%

Value $30.35M Shares 1,152,525 Est. Cost $24.66 Unrealized —

CABA CABALETTA BIO INC 18.5%

Value $28.16M Shares 2,181,377 Est. Cost $3.64 Unrealized +198.1%

— ALPINE IMMUNE SCIENCES INC 18.0%

Value $27.45M Shares 2,670,472 Est. Cost $10.20 Unrealized —

— CYMABAY THERAPEUTICS INC 8.6%

Value $13.2M Shares 1,205,050 Est. Cost $3.16 Unrealized —

TCRX TSCAN THERAPEUTICS INC 8.6%

Value $13.06M Shares 5,224,600 Est. Cost $2.68 Unrealized 0.0%

GHRS GH RESEARCH PLC 7.5%

Value $11.5M Shares 969,374 Est. Cost $10.26 Unrealized 0.0%

— PARDES BIOSCIENCES INC 4.6%

Value $7.063M Shares 3,902,434 Est. Cost $5.14 Unrealized —

— THESEUS PHARMACEUTICALS INC 4.6%

Value $7.063M Shares 757,009 Est. Cost $8.59 Unrealized —

— KINNATE BIOPHARMA INC 4.1%

Value $6.208M Shares 2,048,736 Est. Cost $10.62 Unrealized —

— NEOLEUKIN THERAPEUTICS INC 1.7%

Value $2.568M Shares 3,094,554 Est. Cost $0.59 Unrealized —

— PIERIS PHARMACEUTICALS INC 1.1%

Value $1.618M Shares 9,775,849 Est. Cost $1.23 Unrealized —

CGEM CULLINAN ONCOLOGY INC 0.8%

Value $1.238M Shares 115,063 Est. Cost $10.62 Unrealized 0.0%

— PASSAGE BIO INC 0.7%

Value $1.099M Shares 1,167,343 Est. Cost $1.43 Unrealized —

GPCR STRUCTURE THERAPEUTICS INC 0.6%

Value $956K Shares 23,000 Est. Cost $23.79 Unrealized —

— ATHIRA PHARMA INC 0.4%

Value $571K Shares 193,573 Est. Cost $2.95 Unrealized —

PHVS PHARVARIS N V 0.2%

Value $321K Shares 21,225 Est. Cost $5.38 Unrealized +79.0%

CMPS COMPASS PATHWAYS PLC 0.1%

Value $167K Shares 20,114 Est. Cost $8.28 Unrealized —

— DBV TECHNOLOGIES S A 0.0%

Value $34,704 Shares 18,265 Est. Cost $1.90 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	1,152,525	$30.35M	19.9%	$24.66	—	COM	N5749R100
CABA	CABALETTA BIO INC	2,181,377	$28.16M	18.5%	$3.64	+198.1%	COM	12674W109
—	ALPINE IMMUNE SCIENCES INC	2,670,472	$27.45M	18.0%	$10.20	—	COM	02083G100
—	CYMABAY THERAPEUTICS INC	1,205,050	$13.2M	8.6%	$3.16	—	COM	23257D103
TCRX	TSCAN THERAPEUTICS INC	5,224,600	$13.06M	8.6%	$2.68	0.0%	COM	89854M101
GHRS	GH RESEARCH PLC	969,374	$11.5M	7.5%	$10.26	0.0%	ORDINARY SHARES	G3855L106
—	PARDES BIOSCIENCES INC	3,902,434	$7.063M	4.6%	$5.14	—	COM	69945Q105
—	THESEUS PHARMACEUTICALS INC	757,009	$7.063M	4.6%	$8.59	—	COM	88369M101
—	KINNATE BIOPHARMA INC	2,048,736	$6.208M	4.1%	$10.62	—	COM	49705R105
—	NEOLEUKIN THERAPEUTICS INC	3,094,554	$2.568M	1.7%	$0.59	—	COM	64049K104
—	PIERIS PHARMACEUTICALS INC	9,775,849	$1.618M	1.1%	$1.23	—	COM	720795103
CGEM	CULLINAN ONCOLOGY INC	115,063	$1.238M	0.8%	$10.62	0.0%	COM	230031106
—	PASSAGE BIO INC	1,167,343	$1.099M	0.7%	$1.43	—	COM	702712100
GPCR	STRUCTURE THERAPEUTICS INC	23,000	$956K	0.6%	$23.79	—	SPONSORED ADS	86366E106
—	ATHIRA PHARMA INC	193,573	$571K	0.4%	$2.95	—	COM	04746L104
PHVS	PHARVARIS N V	21,225	$321K	0.2%	$5.38	+79.0%	COM	N69605108
CMPS	COMPASS PATHWAYS PLC	20,114	$167K	0.1%	$8.28	—	SPONSORED ADS	20451W101
—	DBV TECHNOLOGIES S A	18,265	$34,704	0.0%	$1.90	—	SPONSORED ADR	23306J101